Lumen Bioscience, Inc.
7 clinical trials · Sponsor
◉ Watch Lumen Bioscience, Inc.
| Record | Firm | Date |
|---|---|---|
| LMN-201 for Prevention of C. Difficile Infection Recurrence (NCT05330182) | Lumen Bioscience, Inc. | 2024-08-29 |
| Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia (NCT06363890) | Lumen Bioscience, Inc. | 2024-06-20 |
| A Study to Determine the Tolerability of Intranasal LMN-301 (NCT06030414) | Lumen Bioscience, Inc. | 2023-10-06 |
| LMN-101 in a Campylobacter Human Challenge Model (NCT04182490) | Lumen Bioscience, Inc. | 2022-02-21 |
| Safety and Pharmacokinetic Study of LMN-101 in Healthy Volunteers (NCT04098263) | Lumen Bioscience, Inc. | 2019-11-15 |
Track Lumen Bioscience, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.